[CHM] QoQ Quarter Result on 31-Mar-2023 [#Q3]

Stock
[CHM] Chimeric Therapeutics Limited
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q3]
Profit Trend
QoQ- 39.69%
YoY- -128.18%
Quarter Report
CHM's Result
CHM's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 5,485 5,485 706 706 1,505 1,505 1,309 159.23%
PBT -3,471 1,186 -15,592 -7,090 -14,737 -5,822 -6,046 -30.85%
Tax -5,915 36 -1,423 6 -2,990 52 164 -
NP 2,444 1,222 -14,169 -7,085 -11,748 -5,874 -6,209 -
Tax Rate - -3.08% - - - - - -
Total Cost 3,041 4,263 14,875 7,790 13,252 7,379 7,518 -45.21%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 44.56 22.28 -2,007.51 -1,003.76 -780.61 -390.30 -474.53 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.00 0.00 -0.03 -0.02 -0.03 -0.01 -0.02 -
EPS Diluted 0.00 0.00 -0.03 -0.02 -0.03 -0.01 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.